The global Active Pharmaceutical Ingredient(API) market was valued at 214 million in 2024 and is projected to reach US$ 330 million by 2031, at a CAGR of 6.6% during the forecast period.
Active Pharmaceutical Ingredient (API) is the biologically active component of a drug product (tablet, capsule, cream, injectable) that produces the intended effects.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Active Pharmaceutical Ingredient(API) manufacturers, suppliers, distributors, and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for Active Pharmaceutical Ingredient(API), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Active Pharmaceutical Ingredient(API). This report contains market size and forecasts of Active Pharmaceutical Ingredient(API) in global, including the following market information:
Global Active Pharmaceutical Ingredient(API) market revenue, 2020-2025, 2026-2031, ($ millions)
Global Active Pharmaceutical Ingredient(API) market sales, 2020-2025, 2026-2031, (K Units)
Global top five Active Pharmaceutical Ingredient(API) companies in 2024 (%)
Total Market by Segment:
Global Active Pharmaceutical Ingredient(API) market, by Type, 2020-2025, 2026-2031 ($ millions) & (K Units)
Global Active Pharmaceutical Ingredient(API) market segment percentages, by Type, 2024 (%)
Generic API
Innovative API
Global Active Pharmaceutical Ingredient(API) market, by Application, 2020-2025, 2026-2031 ($ Millions) & (K Units)
Global Active Pharmaceutical Ingredient(API) market segment percentages, by Application, 2024 (%)
Oncology
Cardiology
Cns and Neurology
Orthopaedic
Pulmonology
Gastroenterology
Nephrology
Ophthalmology
Endocrinology
Global Active Pharmaceutical Ingredient(API) market, by region and country, 2020-2025, 2026-2031 ($ millions) & (K Units)
Global Active Pharmaceutical Ingredient(API) market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Active Pharmaceutical Ingredient(API) revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies Active Pharmaceutical Ingredient(API) revenues share in global market, 2024 (%)
Key companies Active Pharmaceutical Ingredient(API) sales in global market, 2020-2025 (estimated), (K Units)
Key companies Active Pharmaceutical Ingredient(API) sales share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
Teva Pharmaceuticals
Pfizer
Aurobindo Pharma
Sun Pharmaceutical Industries Ltd.
Novartis
Mylan
Boehringer Ingelheim
Merck&Co.
AbbVie
Biocon
Bristol Myers Squibb
C.H.Boehringer Sohn AG&Co.KG
Cipla
Albemarle Corporation
Viatris
Dr. Reddys Laboratories
Outline of Major Chapters:
Chapter 1: Introduces the definition of Active Pharmaceutical Ingredient(API), market overview.
Chapter 2: Global Active Pharmaceutical Ingredient(API) market size in revenue and volume.
Chapter 3: Detailed analysis of Active Pharmaceutical Ingredient(API) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Active Pharmaceutical Ingredient(API) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Active Pharmaceutical Ingredient(API) capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Active Pharmaceutical Ingredient(API) Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global Active Pharmaceutical Ingredient(API) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Active Pharmaceutical Ingredient(API) Overall Market Size
2.1 Global Active Pharmaceutical Ingredient(API) Market Size: 2024 VS 2031
2.2 Global Active Pharmaceutical Ingredient(API) Market Size, Prospects & Forecasts: 2020-2031
2.3 Global Active Pharmaceutical Ingredient(API) Sales: 2020-2031
3 Company Landscape
3.1 Top Active Pharmaceutical Ingredient(API) Players in Global Market
3.2 Top Global Active Pharmaceutical Ingredient(API) Companies Ranked by Revenue
3.3 Global Active Pharmaceutical Ingredient(API) Revenue by Companies
3.4 Global Active Pharmaceutical Ingredient(API) Sales by Companies
3.5 Global Active Pharmaceutical Ingredient(API) Price by Manufacturer (2020-2025)
3.6 Top 3 and Top 5 Active Pharmaceutical Ingredient(API) Companies in Global Market, by Revenue in 2024
3.7 Global Manufacturers Active Pharmaceutical Ingredient(API) Product Type
3.8 Tier 1, Tier 2, and Tier 3 Active Pharmaceutical Ingredient(API) Players in Global Market
3.8.1 List of Global Tier 1 Active Pharmaceutical Ingredient(API) Companies
3.8.2 List of Global Tier 2 and Tier 3 Active Pharmaceutical Ingredient(API) Companies
4 Sights by Product
4.1 Overview
4.1.1 Segment by Type - Global Active Pharmaceutical Ingredient(API) Market Size Markets, 2024 & 2031
4.1.2 Generic API
4.1.3 Innovative API
4.2 Segment by Type - Global Active Pharmaceutical Ingredient(API) Revenue & Forecasts
4.2.1 Segment by Type - Global Active Pharmaceutical Ingredient(API) Revenue, 2020-2025
4.2.2 Segment by Type - Global Active Pharmaceutical Ingredient(API) Revenue, 2026-2031
4.2.3 Segment by Type - Global Active Pharmaceutical Ingredient(API) Revenue Market Share, 2020-2031
4.3 Segment by Type - Global Active Pharmaceutical Ingredient(API) Sales & Forecasts
4.3.1 Segment by Type - Global Active Pharmaceutical Ingredient(API) Sales, 2020-2025
4.3.2 Segment by Type - Global Active Pharmaceutical Ingredient(API) Sales, 2026-2031
4.3.3 Segment by Type - Global Active Pharmaceutical Ingredient(API) Sales Market Share, 2020-2031
4.4 Segment by Type - Global Active Pharmaceutical Ingredient(API) Price (Manufacturers Selling Prices), 2020-2031
5 Sights by Application
5.1 Overview
5.1.1 Segment by Application - Global Active Pharmaceutical Ingredient(API) Market Size, 2024 & 2031
5.1.2 Oncology
5.1.3 Cardiology
5.1.4 Cns and Neurology
5.1.5 Orthopaedic
5.1.6 Pulmonology
5.1.7 Gastroenterology
5.1.8 Nephrology
5.1.9 Ophthalmology
5.1.10 Endocrinology
5.2 Segment by Application - Global Active Pharmaceutical Ingredient(API) Revenue & Forecasts
5.2.1 Segment by Application - Global Active Pharmaceutical Ingredient(API) Revenue, 2020-2025
5.2.2 Segment by Application - Global Active Pharmaceutical Ingredient(API) Revenue, 2026-2031
5.2.3 Segment by Application - Global Active Pharmaceutical Ingredient(API) Revenue Market Share, 2020-2031
5.3 Segment by Application - Global Active Pharmaceutical Ingredient(API) Sales & Forecasts
5.3.1 Segment by Application - Global Active Pharmaceutical Ingredient(API) Sales, 2020-2025
5.3.2 Segment by Application - Global Active Pharmaceutical Ingredient(API) Sales, 2026-2031
5.3.3 Segment by Application - Global Active Pharmaceutical Ingredient(API) Sales Market Share, 2020-2031
5.4 Segment by Application - Global Active Pharmaceutical Ingredient(API) Price (Manufacturers Selling Prices), 2020-2031
6 Sights by Region
6.1 By Region - Global Active Pharmaceutical Ingredient(API) Market Size, 2024 & 2031
6.2 By Region - Global Active Pharmaceutical Ingredient(API) Revenue & Forecasts
6.2.1 By Region - Global Active Pharmaceutical Ingredient(API) Revenue, 2020-2025
6.2.2 By Region - Global Active Pharmaceutical Ingredient(API) Revenue, 2026-2031
6.2.3 By Region - Global Active Pharmaceutical Ingredient(API) Revenue Market Share, 2020-2031
6.3 By Region - Global Active Pharmaceutical Ingredient(API) Sales & Forecasts
6.3.1 By Region - Global Active Pharmaceutical Ingredient(API) Sales, 2020-2025
6.3.2 By Region - Global Active Pharmaceutical Ingredient(API) Sales, 2026-2031
6.3.3 By Region - Global Active Pharmaceutical Ingredient(API) Sales Market Share, 2020-2031
6.4 North America
6.4.1 By Country - North America Active Pharmaceutical Ingredient(API) Revenue, 2020-2031
6.4.2 By Country - North America Active Pharmaceutical Ingredient(API) Sales, 2020-2031
6.4.3 United States Active Pharmaceutical Ingredient(API) Market Size, 2020-2031
6.4.4 Canada Active Pharmaceutical Ingredient(API) Market Size, 2020-2031
6.4.5 Mexico Active Pharmaceutical Ingredient(API) Market Size, 2020-2031
6.5 Europe
6.5.1 By Country - Europe Active Pharmaceutical Ingredient(API) Revenue, 2020-2031
6.5.2 By Country - Europe Active Pharmaceutical Ingredient(API) Sales, 2020-2031
6.5.3 Germany Active Pharmaceutical Ingredient(API) Market Size, 2020-2031
6.5.4 France Active Pharmaceutical Ingredient(API) Market Size, 2020-2031
6.5.5 U.K. Active Pharmaceutical Ingredient(API) Market Size, 2020-2031
6.5.6 Italy Active Pharmaceutical Ingredient(API) Market Size, 2020-2031
6.5.7 Russia Active Pharmaceutical Ingredient(API) Market Size, 2020-2031
6.5.8 Nordic Countries Active Pharmaceutical Ingredient(API) Market Size, 2020-2031
6.5.9 Benelux Active Pharmaceutical Ingredient(API) Market Size, 2020-2031
6.6 Asia
6.6.1 By Region - Asia Active Pharmaceutical Ingredient(API) Revenue, 2020-2031
6.6.2 By Region - Asia Active Pharmaceutical Ingredient(API) Sales, 2020-2031
6.6.3 China Active Pharmaceutical Ingredient(API) Market Size, 2020-2031
6.6.4 Japan Active Pharmaceutical Ingredient(API) Market Size, 2020-2031
6.6.5 South Korea Active Pharmaceutical Ingredient(API) Market Size, 2020-2031
6.6.6 Southeast Asia Active Pharmaceutical Ingredient(API) Market Size, 2020-2031
6.6.7 India Active Pharmaceutical Ingredient(API) Market Size, 2020-2031
6.7 South America
6.7.1 By Country - South America Active Pharmaceutical Ingredient(API) Revenue, 2020-2031
6.7.2 By Country - South America Active Pharmaceutical Ingredient(API) Sales, 2020-2031
6.7.3 Brazil Active Pharmaceutical Ingredient(API) Market Size, 2020-2031
6.7.4 Argentina Active Pharmaceutical Ingredient(API) Market Size, 2020-2031
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Active Pharmaceutical Ingredient(API) Revenue, 2020-2031
6.8.2 By Country - Middle East & Africa Active Pharmaceutical Ingredient(API) Sales, 2020-2031
6.8.3 Turkey Active Pharmaceutical Ingredient(API) Market Size, 2020-2031
6.8.4 Israel Active Pharmaceutical Ingredient(API) Market Size, 2020-2031
6.8.5 Saudi Arabia Active Pharmaceutical Ingredient(API) Market Size, 2020-2031
6.8.6 UAE Active Pharmaceutical Ingredient(API) Market Size, 2020-2031
7 Manufacturers & Brands Profiles
7.1 Teva Pharmaceuticals
7.1.1 Teva Pharmaceuticals Company Summary
7.1.2 Teva Pharmaceuticals Business Overview
7.1.3 Teva Pharmaceuticals Active Pharmaceutical Ingredient(API) Major Product Offerings
7.1.4 Teva Pharmaceuticals Active Pharmaceutical Ingredient(API) Sales and Revenue in Global (2020-2025)
7.1.5 Teva Pharmaceuticals Key News & Latest Developments
7.2 Pfizer
7.2.1 Pfizer Company Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Active Pharmaceutical Ingredient(API) Major Product Offerings
7.2.4 Pfizer Active Pharmaceutical Ingredient(API) Sales and Revenue in Global (2020-2025)
7.2.5 Pfizer Key News & Latest Developments
7.3 Aurobindo Pharma
7.3.1 Aurobindo Pharma Company Summary
7.3.2 Aurobindo Pharma Business Overview
7.3.3 Aurobindo Pharma Active Pharmaceutical Ingredient(API) Major Product Offerings
7.3.4 Aurobindo Pharma Active Pharmaceutical Ingredient(API) Sales and Revenue in Global (2020-2025)
7.3.5 Aurobindo Pharma Key News & Latest Developments
7.4 Sun Pharmaceutical Industries Ltd.
7.4.1 Sun Pharmaceutical Industries Ltd. Company Summary
7.4.2 Sun Pharmaceutical Industries Ltd. Business Overview
7.4.3 Sun Pharmaceutical Industries Ltd. Active Pharmaceutical Ingredient(API) Major Product Offerings
7.4.4 Sun Pharmaceutical Industries Ltd. Active Pharmaceutical Ingredient(API) Sales and Revenue in Global (2020-2025)
7.4.5 Sun Pharmaceutical Industries Ltd. Key News & Latest Developments
7.5 Novartis
7.5.1 Novartis Company Summary
7.5.2 Novartis Business Overview
7.5.3 Novartis Active Pharmaceutical Ingredient(API) Major Product Offerings
7.5.4 Novartis Active Pharmaceutical Ingredient(API) Sales and Revenue in Global (2020-2025)
7.5.5 Novartis Key News & Latest Developments
7.6 Mylan
7.6.1 Mylan Company Summary
7.6.2 Mylan Business Overview
7.6.3 Mylan Active Pharmaceutical Ingredient(API) Major Product Offerings
7.6.4 Mylan Active Pharmaceutical Ingredient(API) Sales and Revenue in Global (2020-2025)
7.6.5 Mylan Key News & Latest Developments
7.7 Boehringer Ingelheim
7.7.1 Boehringer Ingelheim Company Summary
7.7.2 Boehringer Ingelheim Business Overview
7.7.3 Boehringer Ingelheim Active Pharmaceutical Ingredient(API) Major Product Offerings
7.7.4 Boehringer Ingelheim Active Pharmaceutical Ingredient(API) Sales and Revenue in Global (2020-2025)
7.7.5 Boehringer Ingelheim Key News & Latest Developments
7.8 Merck&Co.
7.8.1 Merck&Co. Company Summary
7.8.2 Merck&Co. Business Overview
7.8.3 Merck&Co. Active Pharmaceutical Ingredient(API) Major Product Offerings
7.8.4 Merck&Co. Active Pharmaceutical Ingredient(API) Sales and Revenue in Global (2020-2025)
7.8.5 Merck&Co. Key News & Latest Developments
7.9 AbbVie
7.9.1 AbbVie Company Summary
7.9.2 AbbVie Business Overview
7.9.3 AbbVie Active Pharmaceutical Ingredient(API) Major Product Offerings
7.9.4 AbbVie Active Pharmaceutical Ingredient(API) Sales and Revenue in Global (2020-2025)
7.9.5 AbbVie Key News & Latest Developments
7.10 Biocon
7.10.1 Biocon Company Summary
7.10.2 Biocon Business Overview
7.10.3 Biocon Active Pharmaceutical Ingredient(API) Major Product Offerings
7.10.4 Biocon Active Pharmaceutical Ingredient(API) Sales and Revenue in Global (2020-2025)
7.10.5 Biocon Key News & Latest Developments
7.11 Bristol Myers Squibb
7.11.1 Bristol Myers Squibb Company Summary
7.11.2 Bristol Myers Squibb Business Overview
7.11.3 Bristol Myers Squibb Active Pharmaceutical Ingredient(API) Major Product Offerings
7.11.4 Bristol Myers Squibb Active Pharmaceutical Ingredient(API) Sales and Revenue in Global (2020-2025)
7.11.5 Bristol Myers Squibb Key News & Latest Developments
7.12 C.H.Boehringer Sohn AG&Co.KG
7.12.1 C.H.Boehringer Sohn AG&Co.KG Company Summary
7.12.2 C.H.Boehringer Sohn AG&Co.KG Business Overview
7.12.3 C.H.Boehringer Sohn AG&Co.KG Active Pharmaceutical Ingredient(API) Major Product Offerings
7.12.4 C.H.Boehringer Sohn AG&Co.KG Active Pharmaceutical Ingredient(API) Sales and Revenue in Global (2020-2025)
7.12.5 C.H.Boehringer Sohn AG&Co.KG Key News & Latest Developments
7.13 Cipla
7.13.1 Cipla Company Summary
7.13.2 Cipla Business Overview
7.13.3 Cipla Active Pharmaceutical Ingredient(API) Major Product Offerings
7.13.4 Cipla Active Pharmaceutical Ingredient(API) Sales and Revenue in Global (2020-2025)
7.13.5 Cipla Key News & Latest Developments
7.14 Albemarle Corporation
7.14.1 Albemarle Corporation Company Summary
7.14.2 Albemarle Corporation Business Overview
7.14.3 Albemarle Corporation Active Pharmaceutical Ingredient(API) Major Product Offerings
7.14.4 Albemarle Corporation Active Pharmaceutical Ingredient(API) Sales and Revenue in Global (2020-2025)
7.14.5 Albemarle Corporation Key News & Latest Developments
7.15 Viatris
7.15.1 Viatris Company Summary
7.15.2 Viatris Business Overview
7.15.3 Viatris Active Pharmaceutical Ingredient(API) Major Product Offerings
7.15.4 Viatris Active Pharmaceutical Ingredient(API) Sales and Revenue in Global (2020-2025)
7.15.5 Viatris Key News & Latest Developments
7.16 Dr. Reddys Laboratories
7.16.1 Dr. Reddys Laboratories Company Summary
7.16.2 Dr. Reddys Laboratories Business Overview
7.16.3 Dr. Reddys Laboratories Active Pharmaceutical Ingredient(API) Major Product Offerings
7.16.4 Dr. Reddys Laboratories Active Pharmaceutical Ingredient(API) Sales and Revenue in Global (2020-2025)
7.16.5 Dr. Reddys Laboratories Key News & Latest Developments
8 Global Active Pharmaceutical Ingredient(API) Production Capacity, Analysis
8.1 Global Active Pharmaceutical Ingredient(API) Production Capacity, 2020-2031
8.2 Active Pharmaceutical Ingredient(API) Production Capacity of Key Manufacturers in Global Market
8.3 Global Active Pharmaceutical Ingredient(API) Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Active Pharmaceutical Ingredient(API) Supply Chain Analysis
10.1 Active Pharmaceutical Ingredient(API) Industry Value Chain
10.2 Active Pharmaceutical Ingredient(API) Upstream Market
10.3 Active Pharmaceutical Ingredient(API) Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Active Pharmaceutical Ingredient(API) Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Active Pharmaceutical Ingredient(API) in Global Market
Table 2. Top Active Pharmaceutical Ingredient(API) Players in Global Market, Ranking by Revenue (2024)
Table 3. Global Active Pharmaceutical Ingredient(API) Revenue by Companies, (US$, Mn), 2020-2025
Table 4. Global Active Pharmaceutical Ingredient(API) Revenue Share by Companies, 2020-2025
Table 5. Global Active Pharmaceutical Ingredient(API) Sales by Companies, (K Units), 2020-2025
Table 6. Global Active Pharmaceutical Ingredient(API) Sales Share by Companies, 2020-2025
Table 7. Key Manufacturers Active Pharmaceutical Ingredient(API) Price (2020-2025) & (US$/Unit)
Table 8. Global Manufacturers Active Pharmaceutical Ingredient(API) Product Type
Table 9. List of Global Tier 1 Active Pharmaceutical Ingredient(API) Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Active Pharmaceutical Ingredient(API) Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 11. Segment by Type – Global Active Pharmaceutical Ingredient(API) Revenue, (US$, Mn), 2024 & 2031
Table 12. Segment by Type - Global Active Pharmaceutical Ingredient(API) Revenue (US$, Mn), 2020-2025
Table 13. Segment by Type - Global Active Pharmaceutical Ingredient(API) Revenue (US$, Mn), 2026-2031
Table 14. Segment by Type - Global Active Pharmaceutical Ingredient(API) Sales (K Units), 2020-2025
Table 15. Segment by Type - Global Active Pharmaceutical Ingredient(API) Sales (K Units), 2026-2031
Table 16. Segment by Application – Global Active Pharmaceutical Ingredient(API) Revenue, (US$, Mn), 2024 & 2031
Table 17. Segment by Application - Global Active Pharmaceutical Ingredient(API) Revenue, (US$, Mn), 2020-2025
Table 18. Segment by Application - Global Active Pharmaceutical Ingredient(API) Revenue, (US$, Mn), 2026-2031
Table 19. Segment by Application - Global Active Pharmaceutical Ingredient(API) Sales, (K Units), 2020-2025
Table 20. Segment by Application - Global Active Pharmaceutical Ingredient(API) Sales, (K Units), 2026-2031
Table 21. By Region – Global Active Pharmaceutical Ingredient(API) Revenue, (US$, Mn), 2025-2031
Table 22. By Region - Global Active Pharmaceutical Ingredient(API) Revenue, (US$, Mn), 2020-2025
Table 23. By Region - Global Active Pharmaceutical Ingredient(API) Revenue, (US$, Mn), 2026-2031
Table 24. By Region - Global Active Pharmaceutical Ingredient(API) Sales, (K Units), 2020-2025
Table 25. By Region - Global Active Pharmaceutical Ingredient(API) Sales, (K Units), 2026-2031
Table 26. By Country - North America Active Pharmaceutical Ingredient(API) Revenue, (US$, Mn), 2020-2025
Table 27. By Country - North America Active Pharmaceutical Ingredient(API) Revenue, (US$, Mn), 2026-2031
Table 28. By Country - North America Active Pharmaceutical Ingredient(API) Sales, (K Units), 2020-2025
Table 29. By Country - North America Active Pharmaceutical Ingredient(API) Sales, (K Units), 2026-2031
Table 30. By Country - Europe Active Pharmaceutical Ingredient(API) Revenue, (US$, Mn), 2020-2025
Table 31. By Country - Europe Active Pharmaceutical Ingredient(API) Revenue, (US$, Mn), 2026-2031
Table 32. By Country - Europe Active Pharmaceutical Ingredient(API) Sales, (K Units), 2020-2025
Table 33. By Country - Europe Active Pharmaceutical Ingredient(API) Sales, (K Units), 2026-2031
Table 34. By Region - Asia Active Pharmaceutical Ingredient(API) Revenue, (US$, Mn), 2020-2025
Table 35. By Region - Asia Active Pharmaceutical Ingredient(API) Revenue, (US$, Mn), 2026-2031
Table 36. By Region - Asia Active Pharmaceutical Ingredient(API) Sales, (K Units), 2020-2025
Table 37. By Region - Asia Active Pharmaceutical Ingredient(API) Sales, (K Units), 2026-2031
Table 38. By Country - South America Active Pharmaceutical Ingredient(API) Revenue, (US$, Mn), 2020-2025
Table 39. By Country - South America Active Pharmaceutical Ingredient(API) Revenue, (US$, Mn), 2026-2031
Table 40. By Country - South America Active Pharmaceutical Ingredient(API) Sales, (K Units), 2020-2025
Table 41. By Country - South America Active Pharmaceutical Ingredient(API) Sales, (K Units), 2026-2031
Table 42. By Country - Middle East & Africa Active Pharmaceutical Ingredient(API) Revenue, (US$, Mn), 2020-2025
Table 43. By Country - Middle East & Africa Active Pharmaceutical Ingredient(API) Revenue, (US$, Mn), 2026-2031
Table 44. By Country - Middle East & Africa Active Pharmaceutical Ingredient(API) Sales, (K Units), 2020-2025
Table 45. By Country - Middle East & Africa Active Pharmaceutical Ingredient(API) Sales, (K Units), 2026-2031
Table 46. Teva Pharmaceuticals Company Summary
Table 47. Teva Pharmaceuticals Active Pharmaceutical Ingredient(API) Product Offerings
Table 48. Teva Pharmaceuticals Active Pharmaceutical Ingredient(API) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 49. Teva Pharmaceuticals Key News & Latest Developments
Table 50. Pfizer Company Summary
Table 51. Pfizer Active Pharmaceutical Ingredient(API) Product Offerings
Table 52. Pfizer Active Pharmaceutical Ingredient(API) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 53. Pfizer Key News & Latest Developments
Table 54. Aurobindo Pharma Company Summary
Table 55. Aurobindo Pharma Active Pharmaceutical Ingredient(API) Product Offerings
Table 56. Aurobindo Pharma Active Pharmaceutical Ingredient(API) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 57. Aurobindo Pharma Key News & Latest Developments
Table 58. Sun Pharmaceutical Industries Ltd. Company Summary
Table 59. Sun Pharmaceutical Industries Ltd. Active Pharmaceutical Ingredient(API) Product Offerings
Table 60. Sun Pharmaceutical Industries Ltd. Active Pharmaceutical Ingredient(API) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 61. Sun Pharmaceutical Industries Ltd. Key News & Latest Developments
Table 62. Novartis Company Summary
Table 63. Novartis Active Pharmaceutical Ingredient(API) Product Offerings
Table 64. Novartis Active Pharmaceutical Ingredient(API) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 65. Novartis Key News & Latest Developments
Table 66. Mylan Company Summary
Table 67. Mylan Active Pharmaceutical Ingredient(API) Product Offerings
Table 68. Mylan Active Pharmaceutical Ingredient(API) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 69. Mylan Key News & Latest Developments
Table 70. Boehringer Ingelheim Company Summary
Table 71. Boehringer Ingelheim Active Pharmaceutical Ingredient(API) Product Offerings
Table 72. Boehringer Ingelheim Active Pharmaceutical Ingredient(API) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 73. Boehringer Ingelheim Key News & Latest Developments
Table 74. Merck&Co. Company Summary
Table 75. Merck&Co. Active Pharmaceutical Ingredient(API) Product Offerings
Table 76. Merck&Co. Active Pharmaceutical Ingredient(API) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 77. Merck&Co. Key News & Latest Developments
Table 78. AbbVie Company Summary
Table 79. AbbVie Active Pharmaceutical Ingredient(API) Product Offerings
Table 80. AbbVie Active Pharmaceutical Ingredient(API) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 81. AbbVie Key News & Latest Developments
Table 82. Biocon Company Summary
Table 83. Biocon Active Pharmaceutical Ingredient(API) Product Offerings
Table 84. Biocon Active Pharmaceutical Ingredient(API) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 85. Biocon Key News & Latest Developments
Table 86. Bristol Myers Squibb Company Summary
Table 87. Bristol Myers Squibb Active Pharmaceutical Ingredient(API) Product Offerings
Table 88. Bristol Myers Squibb Active Pharmaceutical Ingredient(API) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 89. Bristol Myers Squibb Key News & Latest Developments
Table 90. C.H.Boehringer Sohn AG&Co.KG Company Summary
Table 91. C.H.Boehringer Sohn AG&Co.KG Active Pharmaceutical Ingredient(API) Product Offerings
Table 92. C.H.Boehringer Sohn AG&Co.KG Active Pharmaceutical Ingredient(API) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 93. C.H.Boehringer Sohn AG&Co.KG Key News & Latest Developments
Table 94. Cipla Company Summary
Table 95. Cipla Active Pharmaceutical Ingredient(API) Product Offerings
Table 96. Cipla Active Pharmaceutical Ingredient(API) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 97. Cipla Key News & Latest Developments
Table 98. Albemarle Corporation Company Summary
Table 99. Albemarle Corporation Active Pharmaceutical Ingredient(API) Product Offerings
Table 100. Albemarle Corporation Active Pharmaceutical Ingredient(API) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 101. Albemarle Corporation Key News & Latest Developments
Table 102. Viatris Company Summary
Table 103. Viatris Active Pharmaceutical Ingredient(API) Product Offerings
Table 104. Viatris Active Pharmaceutical Ingredient(API) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 105. Viatris Key News & Latest Developments
Table 106. Dr. Reddys Laboratories Company Summary
Table 107. Dr. Reddys Laboratories Active Pharmaceutical Ingredient(API) Product Offerings
Table 108. Dr. Reddys Laboratories Active Pharmaceutical Ingredient(API) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 109. Dr. Reddys Laboratories Key News & Latest Developments
Table 110. Active Pharmaceutical Ingredient(API) Capacity of Key Manufacturers in Global Market, 2023-2025 (K Units)
Table 111. Global Active Pharmaceutical Ingredient(API) Capacity Market Share of Key Manufacturers, 2023-2025
Table 112. Global Active Pharmaceutical Ingredient(API) Production by Region, 2020-2025 (K Units)
Table 113. Global Active Pharmaceutical Ingredient(API) Production by Region, 2026-2031 (K Units)
Table 114. Active Pharmaceutical Ingredient(API) Market Opportunities & Trends in Global Market
Table 115. Active Pharmaceutical Ingredient(API) Market Drivers in Global Market
Table 116. Active Pharmaceutical Ingredient(API) Market Restraints in Global Market
Table 117. Active Pharmaceutical Ingredient(API) Raw Materials
Table 118. Active Pharmaceutical Ingredient(API) Raw Materials Suppliers in Global Market
Table 119. Typical Active Pharmaceutical Ingredient(API) Downstream
Table 120. Active Pharmaceutical Ingredient(API) Downstream Clients in Global Market
Table 121. Active Pharmaceutical Ingredient(API) Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Active Pharmaceutical Ingredient(API) Product Picture
Figure 2. Active Pharmaceutical Ingredient(API) Segment by Type in 2024
Figure 3. Active Pharmaceutical Ingredient(API) Segment by Application in 2024
Figure 4. Global Active Pharmaceutical Ingredient(API) Market Overview: 2024
Figure 5. Key Caveats
Figure 6. Global Active Pharmaceutical Ingredient(API) Market Size: 2024 VS 2031 (US$, Mn)
Figure 7. Global Active Pharmaceutical Ingredient(API) Revenue: 2020-2031 (US$, Mn)
Figure 8. Active Pharmaceutical Ingredient(API) Sales in Global Market: 2020-2031 (K Units)
Figure 9. The Top 3 and 5 Players Market Share by Active Pharmaceutical Ingredient(API) Revenue in 2024
Figure 10. Segment by Type – Global Active Pharmaceutical Ingredient(API) Revenue, (US$, Mn), 2024 & 2031
Figure 11. Segment by Type - Global Active Pharmaceutical Ingredient(API) Revenue Market Share, 2020-2031
Figure 12. Segment by Type - Global Active Pharmaceutical Ingredient(API) Sales Market Share, 2020-2031
Figure 13. Segment by Type - Global Active Pharmaceutical Ingredient(API) Price (US$/Unit), 2020-2031
Figure 14. Segment by Application – Global Active Pharmaceutical Ingredient(API) Revenue, (US$, Mn), 2024 & 2031
Figure 15. Segment by Application - Global Active Pharmaceutical Ingredient(API) Revenue Market Share, 2020-2031
Figure 16. Segment by Application - Global Active Pharmaceutical Ingredient(API) Sales Market Share, 2020-2031
Figure 17. Segment by Application -Global Active Pharmaceutical Ingredient(API) Price (US$/Unit), 2020-2031
Figure 18. By Region – Global Active Pharmaceutical Ingredient(API) Revenue, (US$, Mn), 2025 & 2031
Figure 19. By Region - Global Active Pharmaceutical Ingredient(API) Revenue Market Share, 2020 VS 2024 VS 2031
Figure 20. By Region - Global Active Pharmaceutical Ingredient(API) Revenue Market Share, 2020-2031
Figure 21. By Region - Global Active Pharmaceutical Ingredient(API) Sales Market Share, 2020-2031
Figure 22. By Country - North America Active Pharmaceutical Ingredient(API) Revenue Market Share, 2020-2031
Figure 23. By Country - North America Active Pharmaceutical Ingredient(API) Sales Market Share, 2020-2031
Figure 24. United States Active Pharmaceutical Ingredient(API) Revenue, (US$, Mn), 2020-2031
Figure 25. Canada Active Pharmaceutical Ingredient(API) Revenue, (US$, Mn), 2020-2031
Figure 26. Mexico Active Pharmaceutical Ingredient(API) Revenue, (US$, Mn), 2020-2031
Figure 27. By Country - Europe Active Pharmaceutical Ingredient(API) Revenue Market Share, 2020-2031
Figure 28. By Country - Europe Active Pharmaceutical Ingredient(API) Sales Market Share, 2020-2031
Figure 29. Germany Active Pharmaceutical Ingredient(API) Revenue, (US$, Mn), 2020-2031
Figure 30. France Active Pharmaceutical Ingredient(API) Revenue, (US$, Mn), 2020-2031
Figure 31. U.K. Active Pharmaceutical Ingredient(API) Revenue, (US$, Mn), 2020-2031
Figure 32. Italy Active Pharmaceutical Ingredient(API) Revenue, (US$, Mn), 2020-2031
Figure 33. Russia Active Pharmaceutical Ingredient(API) Revenue, (US$, Mn), 2020-2031
Figure 34. Nordic Countries Active Pharmaceutical Ingredient(API) Revenue, (US$, Mn), 2020-2031
Figure 35. Benelux Active Pharmaceutical Ingredient(API) Revenue, (US$, Mn), 2020-2031
Figure 36. By Region - Asia Active Pharmaceutical Ingredient(API) Revenue Market Share, 2020-2031
Figure 37. By Region - Asia Active Pharmaceutical Ingredient(API) Sales Market Share, 2020-2031
Figure 38. China Active Pharmaceutical Ingredient(API) Revenue, (US$, Mn), 2020-2031
Figure 39. Japan Active Pharmaceutical Ingredient(API) Revenue, (US$, Mn), 2020-2031
Figure 40. South Korea Active Pharmaceutical Ingredient(API) Revenue, (US$, Mn), 2020-2031
Figure 41. Southeast Asia Active Pharmaceutical Ingredient(API) Revenue, (US$, Mn), 2020-2031
Figure 42. India Active Pharmaceutical Ingredient(API) Revenue, (US$, Mn), 2020-2031
Figure 43. By Country - South America Active Pharmaceutical Ingredient(API) Revenue Market Share, 2020-2031
Figure 44. By Country - South America Active Pharmaceutical Ingredient(API) Sales, Market Share, 2020-2031
Figure 45. Brazil Active Pharmaceutical Ingredient(API) Revenue, (US$, Mn), 2020-2031
Figure 46. Argentina Active Pharmaceutical Ingredient(API) Revenue, (US$, Mn), 2020-2031
Figure 47. By Country - Middle East & Africa Active Pharmaceutical Ingredient(API) Revenue, Market Share, 2020-2031
Figure 48. By Country - Middle East & Africa Active Pharmaceutical Ingredient(API) Sales, Market Share, 2020-2031
Figure 49. Turkey Active Pharmaceutical Ingredient(API) Revenue, (US$, Mn), 2020-2031
Figure 50. Israel Active Pharmaceutical Ingredient(API) Revenue, (US$, Mn), 2020-2031
Figure 51. Saudi Arabia Active Pharmaceutical Ingredient(API) Revenue, (US$, Mn), 2020-2031
Figure 52. UAE Active Pharmaceutical Ingredient(API) Revenue, (US$, Mn), 2020-2031
Figure 53. Global Active Pharmaceutical Ingredient(API) Production Capacity (K Units), 2020-2031
Figure 54. The Percentage of Production Active Pharmaceutical Ingredient(API) by Region, 2024 VS 2031
Figure 55. Active Pharmaceutical Ingredient(API) Industry Value Chain
Figure 56. Marketing Channels
